The development of superagonist monoclonal antibodies to human IL-21 in immunotherapy for infection and cancer

The development of superagonist monoclonal antibodies to human IL-21 in immunotherapy for infection and cancer

Updated:  26 April 2017/Responsible Officer:  Director, JCSMR/Page Contact:  Web Manager